HIMS - CIK 0001773751
The table below shows Hims & Hers Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $300.01M | $251.08M | $73.48M | -$26.53M | -$34.41M | -$2.48M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$1.02B | -$19.05M | -$12.11M | $34.70M | -$156.27M | -$39.70M |
| Dividends paid | - | - | - | - | - | - |
Hims & Hers Health, Inc. reported operating cash flow of $300.01M for fiscal year 2025. That is up 19.5% from $251.08M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$74.87M (FY 2019) to $300.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $89.96M | $83.04M | $2.00M | $0.00 | $0.00 | $0.00 |
| Financing cash flow | $729.62M | -$107.84M | -$11.47M | -$33.13M | $235.04M | $47.74M |